Rapid detection of hot-spots via tensor decomposition with applications to crime rate data Y Zhao, H Yan, S Holte, Y Mei Journal of Applied Statistics 49 (7), 1636-1662, 2022 | 11 | 2022 |
Rapid detection of hot-spot by tensor decomposition with application to weekly gonorrhea data Y Zhao, H Yan, SE Holte, RP Kerani, Y Mei International Workshop on Intelligent Statistical Quality Control, 265-286, 2019 | 8 | 2019 |
Impact of molnupiravir treatment on patient-reported coronavirus disease 2019 (COVID-19) symptoms in the Phase 3 MOVe-OUT trial: A randomized, placebo-controlled trial Y Guan, A Puenpatom, MG Johnson, Y Zhang, Y Zhao, J Surber, ... Clin. Infect. Dis, 2023 | 7* | 2023 |
A survey of numerical algorithms that can solve the Lasso problems Y Zhao, X Huo Wiley Interdisciplinary Reviews: Computational Statistics, e1602, 2022 | 7 | 2022 |
Identification of underlying dynamic system from noisy data with splines Y Zhao, X Huo, Y Mei arXiv preprint arXiv:2103.10231, 2021 | 4 | 2021 |
Accelerate the warm-up stage in the Lasso computation via a homotopic approach Y Zhao, X Huo Computational Statistics & Data Analysis 184, 107747, 2023 | 3* | 2023 |
Hot-spots detection in count data by Poisson assisted smooth sparse tensor decomposition Y Zhao, H Xiaoming, M Yajun Journal of Applied Statistics, 1-31, 2022 | 3 | 2022 |
New progress in hot-spots detection, partial-differential-equation-based model identification and statistical computation Y Zhao Georgia Institute of Technology, 2021 | 2 | 2021 |
Number of Repetitions in Re-randomization Tests Y Zhang, Y Zhao, Y Luo arXiv preprint arXiv:2302.05977, 2023 | 1 | 2023 |
Electronic common technical document submission with analysis using R Y Zhao, N Xiao, K Anderson, Y Zhang Clinical Trials 20 (1), 89-92, 2023 | 1 | 2023 |
Some group sequential trials from industry over the last 30 years KM Anderson, Y Zhao, N Xiao, J Ge, HF Weisman Statistics in Biopharmaceutical Research, 1-13, 2024 | | 2024 |
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis SM Patel, YM Kang, KA Im, BL Neuen, SD Anker, DL Bhatt, J Butler, ... Circulation, 2024 | | 2024 |
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE … D Schadendorf, JJ Luke, PA Ascierto, GV Long, P Rutkowski, A Khattak, ... Journal for Immunotherapy of Cancer 12 (3), 2024 | | 2024 |
Group Sequential Design Under Non-proportional Hazards Y Zhao, Y Zhang, L Leon, KM Anderson arXiv preprint arXiv:2312.01723, 2023 | | 2023 |
Adjusted inference for multiple testing procedure in group sequential designs Y Zhao, Q Liu, LZ Sun, KM Anderson arXiv preprint arXiv:2311.15498, 2023 | | 2023 |
76P Safety profile of adjuvant pembrolizumab (pembro) in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC): Pooled analysis of phase III clinical trials JJ Luke, GV Long, C Robert, MS Carlino, TK Choueiri, NB Haas, ... Immuno-Oncology and Technology 16, 2022 | | 2022 |
The appreciation of statistical thoughts Y Zhao Statistical Theory and Related Fields 3 (1), 83-84, 2019 | | 2019 |